Immediate iFR-Guided PCI Not Superior to Deferred CMR in STEMI, MVD: iMODERN Registry Oct 28, 2025 by Natalie Morrison, CRTonline.org Performing instantaneous wave-free ratio (iFR) guided percutaneous coronary intervention (PCI) on non-culprit lesions during the initial revascularization procedure for ST-segment elevation myocardial infarction (STEMI) with multivessel disease (MVD) did not reduce major adverse cardiac events (MACE) versus deferred procedures at 3 years, the iMODERN randomized superiority trial found
doi: 10.3389/fendo.2025.1501984 Received 26 September 2024 Accepted 25 April 2025 Published 26 May 2025 Volume 16 - 2025 Edited by Hwi Seung Kim, Chung-Ang University Gwangmyeong Hospital, Republic of Korea Reviewed by Andrej Belani, Clinical Hospital Centre Rijeka, Croatia ukasz Budak, Medical University of Silesia, Poland Updates Copyright 2025 Oe, Omori, Aimono, Furukawa, Kitakawa, Tateno, Sakai and Cho
Medications can be utilized to aid in sleep, but frequently result in a feeling of grogginess upon waking
Transient and mostly mild-to-moderate gastrointestinal symptoms were the most frequently reported AE and occurred more frequently with the 4 mg starting dose groups rather than the 2 mg starting dose groups [67]
What is Glutathione?: Glutathione is widely recognized in Korea as an effective ingredient for antioxidant
To prolong the half-life of Exenatide, a water in oil in oil (W/O/O) method was employed to prepare exenatide-loaded PLGA microspheres
